Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jelena Savović"'
Autor:
Jonathan AC Sterne, Pritesh N Bodalia, Peter A Bryden, Philippa A Davies, Jose A López-López, George N Okoli, Howard HZ Thom, Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian PT Higgins, Will Hollingworth, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Nicky J Welton, Aroon D Hingorani
Publikováno v:
Health Technology Assessment, Vol 21, Iss 9 (2017)
Background: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during hospitalisation can be reduced by low-molecular-weight heparin (L
Externí odkaz:
https://doaj.org/article/2145ae33ef2a41f69eb5c98fa9cf337a
Autor:
Chris Salisbury, Wei Fang, Annya Stephens-Boal, Reecha Sofat, Philippa Davies, Diane Eaton, Zhenru Wang, Howard Thom, Aroon D. Hingorani, Peter Bryden, Alison Richards, William Hollingworth, José A López-López, Jelena Savović, Nicky J Welton, Jonathan A C Sterne, Sofia Dias, Deborah M Caldwell, Pritesh N Bodalia, Julian P T Higgins, G N Okoli
Publikováno v:
MDM Policy & Practice
Thom, H, Hollingworth, W, Sofat, R, Wang, Z, Fang, W, Bodalia, P N, Bryden, P, Davies, P, Caldwell, D, Dias, S, Eaton, D, Higgins, J, Hingorani, A D, Lopez-Lopez, J, Okoli, G, Richards, A, Salisbury, C, Savović, J, Stephens-Boal, A, Sterne, J & Welton, N 2019, ' Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales : Cost-Effectiveness Model and Value of Information Analysis ', MDM Policy & Practice, vol. 4, no. 2 . https://doi.org/10.1177/2381468319866828
MDM Policy & Practice, Vol 4 (2019)
Thom, H, Hollingworth, W, Sofat, R, Wang, Z, Fang, W, Bodalia, P N, Bryden, P, Davies, P, Caldwell, D, Dias, S, Eaton, D, Higgins, J, Hingorani, A D, Lopez-Lopez, J, Okoli, G, Richards, A, Salisbury, C, Savović, J, Stephens-Boal, A, Sterne, J & Welton, N 2019, ' Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales : Cost-Effectiveness Model and Value of Information Analysis ', MDM Policy & Practice, vol. 4, no. 2 . https://doi.org/10.1177/2381468319866828
MDM Policy & Practice, Vol 4 (2019)
Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK National Health Service (NHS) perspective and estimate val
Autor:
Aroon D. Hingorani, William Hollingworth, Chris Salisbury, Howard Thom, Annya Stephens-Boal, Sofia Dias, Jelena Savović, Reecha Sofat, Philippa Davies, Jonathan A C Sterne, José A López-López, Diane Eaton, Nicky J Welton, Pritesh N Bodalia, Julian P T Higgins, Peter Bryden, G N Okoli, Deborah M Caldwell
Publikováno v:
López-López, J A, Sterne, J A C, Thom, H H Z, Higgins, J P T, Hingorani, A D, Okoli, G N, Davies, P A, Bodalia, P N, Bryden, P A, Welton, N J, Hollingworth, W, Caldwell, D M, Savović, J, Dias, S, Salisbury, C, Eaton, D, Stephens-Boal, A & Sofat, R 2017, ' Oral anticoagulants for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis, and cost effectiveness analysis ', BMJ, vol. 359, j5058 . https://doi.org/10.1136/bmj.j5058
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review, network meta-analysis, and cost effectiveness analysis. Data sources Medli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e89f4f6471e04cb68f130708cd201665
https://research-information.bris.ac.uk/en/publications/8c179c5b-3adf-42f3-b6e8-8c7084a4198c
https://research-information.bris.ac.uk/en/publications/8c179c5b-3adf-42f3-b6e8-8c7084a4198c
Autor:
Chris Salisbury, Philippa Davies, G N Okoli, Sofia Dias, Jonathan A C Sterne, Nicky J Welton, Pritesh N Bodalia, Julian P T Higgins, Jelena Savović, José A López-López, Diane Eaton, Annya Stephens-Boal, Reecha Sofat, Howard Thom, William Hollingworth, Peter Bryden, Deborah M Caldwell, Aroon D. Hingorani
Publikováno v:
ResearcherID
Health Technology Assessment, Vol 21, Iss 9 (2017)
Sterne, J A, Bodalia, P N, Bryden, P A, Davies, P A, López-López, J A, Okoli, G N, Thom, H H, Caldwell, D M, Dias, S, Eaton, D, Higgins, J P, Hollingworth, W, Salisbury, C, Savović, J, Sofat, R, Stephens-Boal, A, Welton, N J & Hingorani, A D 2017, ' Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis and cost-effectiveness analysis ', Health Technology Assessment, vol. 21, no. 9, pp. 1-438 . https://doi.org/10.3310/hta21090
Health Technology Assessment, Vol 21, Iss 9 (2017)
Sterne, J A, Bodalia, P N, Bryden, P A, Davies, P A, López-López, J A, Okoli, G N, Thom, H H, Caldwell, D M, Dias, S, Eaton, D, Higgins, J P, Hollingworth, W, Salisbury, C, Savović, J, Sofat, R, Stephens-Boal, A, Welton, N J & Hingorani, A D 2017, ' Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis and cost-effectiveness analysis ', Health Technology Assessment, vol. 21, no. 9, pp. 1-438 . https://doi.org/10.3310/hta21090
BackgroundWarfarin is effective for stroke prevention in atrial fibrillation (AF), but anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during hospitalisation can be reduced by low-molecular-weight heparin (LMW
Autor:
Aroon D. Hingorani, Diane Eaton, Jelena Savović, Reecha Sofat, Jonathan A C Sterne, Annya Stephens-Boal, G N Okoli, Chris Salisbury, Philippa Davies, José A López-López, Pritesh N Bodalia, Deborah M Caldwell, Julian P T Higgins, Sofia Dias, Howard Thom, Nicky J Welton, Peter Bryden, William Hollingworth
Publikováno v:
Value in Health. 18(7)
Autor:
Howard Thom, Peter Bryden, Pritesh N Bodalia, Julian P T Higgins, Nicky J Welton, Philippa Davies, Annya Stephens-Boal, Reecha Sofat, Deborah M Caldwell, Aroon D. Hingorani, Chris Salisbury, Jonathan A C Sterne, Sofia Dias, William Hollingworth, G N Okoli, Diane Eaton, Jelena Savović, José A López-López
Publikováno v:
Value in Health. 18:A391-A392